The size of the Single-use Bioprocessing Market in LATAM was worth USD 0.32 Billion in 2022. It is estimated to be growing at a CAGR of 17.2% and worth USD 0.70 Billion by 2027.
Single-use bioprocessing technology is a popularly used technique for the manufacturing of biopharmaceuticals. It is applied during the whole procedure of biopharmaceutical production, that is, from buffer and media preparation to shipping of biologics. Single-use bioprocessing procedures involve using different products like manifold assemblies, bioprocess containers and bags, single-use bioreactors, and single-use mixers. They cut the cost of complex bioproduction processes, such as cleaning, sterilization, and care of the big bioreactors.
The developing economy, increasing demand for disposable biopharmaceuticals, and increased spending ability are propelling the growth of the Latin American single-use bioprocessing systems market.
However, insufficient government support, leachability problems, and environmental and economic hazards are the main challenges faced by the single-use bioprocessing market. The market is showing huge potential in the future years and is expected to continue its growth.
This research report segmented and sub-segmented the Latin American Single-use Bioprocessing Market into the following categories:
By Product:
By Application:
By Country:
Companies that are dominating the Latin American Single-use Bioprocessing Market profiled in this report are Thermo Fisher Scientific, Danaher Corporation, GE Healthcare (General Electric Company), Sartorius Stedim Biotech S.A, Merck Millipore (Merck Group), 3M Company, Eppendorf AG, Finesse Solutions, Inc., Applikon Biotechnology B.V., and Cesco Bioengineering Co., Ltd.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Media Bags and Containers
5.1.3 Filtration Assemblies
5.1.4 Single use bio-reactors
5.1.5 Disposable Mixers
5.1.6 Others
5.1.7 Y-o-Y Growth Analysis, By Product
5.1.8 Market Attractiveness Analysis, By Product
5.1.9 Market Share Analysis, By Product
5.2 Application
5.2.1 Introduction
5.2.2 Filtration
5.2.3 Storage
5.2.4 Cell Culture
5.2.5 Mixing
5.2.6 Purification
5.2.7 Y-o-Y Growth Analysis, By Application
5.2.8 Market Attractiveness Analysis, By Application
5.2.9 Market Share Analysis, By Application
5.3 End User
5.3.1 Introduction
5.3.2 Research and Development Institutes
5.3.3 Biopharmaceutical Manufacturers
5.3.4 Y-o-Y Growth Analysis, By End User
5.3.5 Market Attractiveness Analysis, By End User
5.3.6 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Application
6.1.3.4 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Application
6.1.4.4 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Application
6.1.5.4 By End User
6.2 Brazil
6.3 Mexico
6.4 Rest of Latin America
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Thermo Fisher Scientific
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Danaher Corporation
8.3 GE Healthcare
8.4 Sartorius Stedim Biotech S.A
8.5 Merck Millipore
8.6 3M Company
8.7 Eppendorf AG
8.8 Finesse Solutions
8.9 Cytori Therapeutics
8.10 Cesco Bioengineering Co.
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.
